Hilo (formerly Aktiia) manufactures the first FDA-cleared cuffless blood pressure monitor for over-the-counter use. The wristband takes approximately 25 measurements daily through photoplethysmography (PPG) optical sensors, tracking blood pressure 24/7 without inflatable cuffs or manual interventions.
The band retails at £210-300 depending on region, requiring £60-80 annual membership for full app functionality. Initial calibration uses included oscillometric cuff performing three measurements, after which continuous monitoring begins automatically.
Technical Specifications and FDA Clearance
July 2025 FDA 510(k) clearance marked breakthrough moment—first cuffless blood pressure monitor authorized for OTC use in United States. CE Class IIa medical device certification in Europe validates clinical accuracy meeting international standards.
The device measures blood pressure only during stillness, automatically detecting movement before initiating readings. PPG data transmits via Bluetooth to secure cloud servers where algorithms calculate blood pressure through advanced optical signal processing. Battery lasts 15 days per charge.
Hilo vs. Traditional Blood Pressure Monitoring
| Feature | Hilo Band | Traditional Cuff | Omron Smartwatch | Withings BPM Connect |
|---|---|---|---|---|
| Price | £210-300 + £60/year | £30-80 one-time | £499 | £79 |
| Measurements/Day | ~25 automatic | 1-2 manual | On-demand | On-demand |
| Form Factor | Wristband | Arm cuff | Smartwatch | Portable cuff |
| Night Monitoring | Yes (automatic) | No | No | No |
| FDA Status | FDA cleared OTC | FDA approved | Not FDA cleared | FDA cleared |
| Calibration | Initial cuff (included) | Self-contained | Initial cuff required | Self-contained |
| Waterproof | IP68 (full) | No | IP67 | No |
| Data Trends | Continuous tracking | Manual logging | App-based | App-based |
Real User Experiences
Trustpilot reviews average 4.3/5 stars from 5,500+ customers. Medical Futurist’s testing by Dr. Bertalan Mesko praised straightforward setup and comfortable 24-hour wear, noting readings comparable to traditional cuffs.
ZDNet’s review described the band as “stalking the silent killer,” enabling users to identify blood pressure patterns invisible through sporadic manual measurements. Multiple users report discovering morning hypertension spikes previously undetected during daytime-only cuff monitoring.
Critical feedback centers on subscription frustrations. Early Aktiia adopters received lifetime free access, while new Hilo customers face mandatory £60 annual fees for full functionality. Customer service complaints describe two-week response delays and difficulty resolving warranty issues despite premium pricing.
Accuracy varies by individual physiology. Some users report readings consistently 5-10 points higher than cuff measurements, while others find excellent correlation. TechRadar’s G1 review emphasized readings fall within acceptable clinical ranges validated through multiple trials.
Clinical Validation and Medical Perspective
20+ years research investment produced 12 billion data points training AI algorithms. Six major clinical trials validated accuracy meeting international standards for home blood pressure monitors. Studies demonstrate persistent Hilo use associates with lower blood pressure in hypertensive patients—5mmHg average reduction after 6 months.
Dr. Jay Shah, Chief Medical Officer at Aktiia, explains continuous monitoring reveals fluctuations traditional spot-checks miss: “The Hilo Band enables patients, doctors, and caregivers to understand blood pressure patterns in real-time, making it easier to pinpoint causes for fluctuations.”
However, Medical Design & Outsourcing interview with CTO Josep Solà acknowledged calibration represents biggest technical challenge. The integrated cuff solution automates recalibration “silently in the background” but requires periodic validation measurements users sometimes forget.
Membership Economics
Hilo shifted from one-time purchase to subscription model creating customer confusion:
Original Aktiia Buyers (pre-2024):
- Lifetime free access to original features
- Optional upgrades to new Hilo features via subscription
New Hilo Buyers (2024+):
- Band: £210-300
- Mandatory membership: £60/year (€80 in Europe)
- Membership includes unlimited phone camera measurements, advanced insights, personalized recommendations
First-year cost: £270-360 total
Critics argue subscription fees feel excessive after £210+ hardware investment, particularly when competing smartwatches integrate blood pressure estimation without ongoing fees (though lacking FDA clearance).
Usage Considerations
IP68 waterproof rating permits showering and swimming. 15-day battery life reduces charging frequency versus daily smartwatch requirements. Comfortable silicone band weighs under 100 grams—unnoticeable during sleep.
Setup requires three cuff measurements calibrating optical sensors to individual physiology. Recalibration prompts appear monthly ensuring accuracy maintenance. Readings appear automatically in app averaging measurements across timeframes reducing single-datapoint anxiety.
Final Assessment
Hilo delivers legitimate 24/7 blood pressure monitoring through validated medical-grade technology earning FDA clearance competitors cannot match. Continuous data reveals hypertension patterns invisible through traditional spot-checking, potentially improving cardiovascular outcomes through earlier intervention and lifestyle adjustment insights.
However, subscription economics and customer service inconsistencies create friction. For hypertensive patients requiring serious monitoring and comfortable with £270-360 annual investment, Hilo provides compelling clinical value. Casual users wanting occasional spot-checks find better value in traditional cuffs or one-time purchase alternatives.
